688317 之江生物
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额32,67277,589(81,885)584,971641,937
投资活动产生之现金流量净额(319,238)(19,416)(77,689)(76,021)(519,061)
筹资活动产生之现金流量净额(26,848)(58,720)(234,393)(371,404)1,628,003
汇率变动对现金及现金等价物的影响(9,676)14,44215,77374,354(19,816)
现金及现金等价物净增加/(减少)(323,089)13,894(378,194)211,9001,731,063
期初现金及现金等价物余额2,783,3932,769,2823,147,4762,935,5751,204,512
期末现金及现金等价物余额2,460,3032,783,1762,769,2823,147,4762,935,575